These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 38704599)

  • 1. Iron metabolism: backfire of cancer cell stemness and therapeutic modalities.
    Yu R; Hang Y; Tsai HI; Wang D; Zhu H
    Cancer Cell Int; 2024 May; 24(1):157. PubMed ID: 38704599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-resistant nature of cancer stem cells in view of iron metabolism.
    Wang W; Tabu K; Aimaitijiang A; Taga T
    Inflamm Regen; 2022 Nov; 42(1):34. PubMed ID: 36324180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradicating the tumor "seeds": nanomedicines-based therapies against cancer stem cells.
    Li L; Ni R; Zheng D; Chen L
    Daru; 2023 Jun; 31(1):83-94. PubMed ID: 36971921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis: Cancer Stem Cells Rely on Iron until "to Die for" It.
    Cosialls E; El Hage R; Dos Santos L; Gong C; Mehrpour M; Hamaï A
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells: advances in the glucose, lipid and amino acid metabolism.
    Kong W; Gao Y; Zhao S; Yang H
    Mol Cell Biochem; 2024 Oct; 479(10):2545-2563. PubMed ID: 37882986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells.
    Yu CH; Yu CC
    PLoS One; 2014; 9(1):e87129. PubMed ID: 24475244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in drug delivery systems for targeting cancer stem cells.
    Duan H; Liu Y; Gao Z; Huang W
    Acta Pharm Sin B; 2021 Jan; 11(1):55-70. PubMed ID: 33532180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of iron metabolism and ferroptosis in cancer stem cells.
    Wang H; Zhang Z; Ruan S; Yan Q; Chen Y; Cui J; Wang X; Huang S; Hou B
    Front Oncol; 2023; 13():1251561. PubMed ID: 37736551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells.
    Singh SP; Singh R; Gupta OP; Gupta S; Brahma Bhatt ML
    J Oncol; 2020; 2020():3963561. PubMed ID: 32211043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells: a target for overcoming therapeutic resistance and relapse.
    Zhang S; Yang R; Ouyang Y; Shen Y; Hu L; Xu C
    Cancer Biol Med; 2023 Dec; 20(12):985-1020. PubMed ID: 38164743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between amino acid metabolism and self-renewal of cancer stem cells: Perspectives in cancer therapy.
    Zhang Q; Li W
    World J Stem Cells; 2022 Apr; 14(4):267-286. PubMed ID: 35662861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine strategies to counteract cancer stemness and chemoresistance.
    Liu H; Liu M; Zhao Y; Mo R
    Explor Target Antitumor Ther; 2023; 4(4):630-656. PubMed ID: 37720349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation.
    Xiao C; Fu X; Wang Y; Liu H; Jiang Y; Zhao Z; You F
    PLoS One; 2020; 15(12):e0243812. PubMed ID: 33351833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
    Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
    World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted immunotherapy to cancer stem cells: A novel strategy of anticancer immunotherapy.
    Yi SY; Wei MZ; Zhao L
    Crit Rev Oncol Hematol; 2024 Apr; 196():104313. PubMed ID: 38428702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs: Emerging regulators for chemo/immunotherapy resistance in cancer stem cells.
    Shen C; Yang C; Xia B; You M
    Cancer Lett; 2021 Mar; 500():244-252. PubMed ID: 33242560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances of nanotechnology applied to cancer stem cells.
    Yue M; Guo T; Nie DY; Zhu YX; Lin M
    World J Stem Cells; 2023 Jun; 15(6):514-529. PubMed ID: 37424953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron depletion is a novel therapeutic strategy to target cancer stem cells.
    Ninomiya T; Ohara T; Noma K; Katsura Y; Katsube R; Kashima H; Kato T; Tomono Y; Tazawa H; Kagawa S; Shirakawa Y; Kimura F; Chen L; Kasai T; Seno M; Matsukawa A; Fujiwara T
    Oncotarget; 2017 Nov; 8(58):98405-98416. PubMed ID: 29228699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.